Global New Psychoactive Substance Supply, Demand and Key Producers, 2023-2029

Page: 109

Published Date: 30 Aug 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global New Psychoactive Substance market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global New Psychoactive Substance demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for New Psychoactive Substance, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of New Psychoactive Substance that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global New Psychoactive Substance total market, 2018-2029, (USD Million)
Global New Psychoactive Substance total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: New Psychoactive Substance total market, key domestic companies and share, (USD Million)
Global New Psychoactive Substance revenue by player and market share 2018-2023, (USD Million)
Global New Psychoactive Substance total market by Type, CAGR, 2018-2029, (USD Million)
Global New Psychoactive Substance total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global New Psychoactive Substance market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zynerba Pharmaceuticals, GW Pharmaceuticals, Teewinot Life Sciences, AusCann, Cannabics Pharmaceuticals, Tilray, Cyrelian, Anandia Laboratories and InMed Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World New Psychoactive Substance market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global New Psychoactive Substance Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global New Psychoactive Substance Market, Segmentation by Type
    Stimulants
    Cannabinoids
    Hallucinogens
    Depressants

Global New Psychoactive Substance Market, Segmentation by Application
    Cancer
    Neuropathic Disorders
    Spasticity
    Others

Companies Profiled:
    Zynerba Pharmaceuticals
    GW Pharmaceuticals
    Teewinot Life Sciences
    AusCann
    Cannabics Pharmaceuticals
    Tilray
    Cyrelian
    Anandia Laboratories
    InMed Pharmaceuticals
    Renew Biopharma
    Cronos Group
    ICC International Cannabis
    Biotii Technologies

Key Questions Answered
1. How big is the global New Psychoactive Substance market?
2. What is the demand of the global New Psychoactive Substance market?
3. What is the year over year growth of the global New Psychoactive Substance market?
4. What is the total value of the global New Psychoactive Substance market?
5. Who are the major players in the global New Psychoactive Substance market?

Table of Contents

1 Supply Summary
    1.1 New Psychoactive Substance Introduction
    1.2 World New Psychoactive Substance Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World New Psychoactive Substance Total Market by Region (by Headquarter Location)
        1.3.1 World New Psychoactive Substance Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States New Psychoactive Substance Market Size (2018-2029)
        1.3.3 China New Psychoactive Substance Market Size (2018-2029)
        1.3.4 Europe New Psychoactive Substance Market Size (2018-2029)
        1.3.5 Japan New Psychoactive Substance Market Size (2018-2029)
        1.3.6 South Korea New Psychoactive Substance Market Size (2018-2029)
        1.3.7 ASEAN New Psychoactive Substance Market Size (2018-2029)
        1.3.8 India New Psychoactive Substance Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 New Psychoactive Substance Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 New Psychoactive Substance Major Market Trends

2 Demand Summary
    2.1 World New Psychoactive Substance Consumption Value (2018-2029)
    2.2 World New Psychoactive Substance Consumption Value by Region
        2.2.1 World New Psychoactive Substance Consumption Value by Region (2018-2023)
        2.2.2 World New Psychoactive Substance Consumption Value Forecast by Region (2024-2029)
    2.3 United States New Psychoactive Substance Consumption Value (2018-2029)
    2.4 China New Psychoactive Substance Consumption Value (2018-2029)
    2.5 Europe New Psychoactive Substance Consumption Value (2018-2029)
    2.6 Japan New Psychoactive Substance Consumption Value (2018-2029)
    2.7 South Korea New Psychoactive Substance Consumption Value (2018-2029)
    2.8 ASEAN New Psychoactive Substance Consumption Value (2018-2029)
    2.9 India New Psychoactive Substance Consumption Value (2018-2029)

3 World New Psychoactive Substance Companies Competitive Analysis
    3.1 World New Psychoactive Substance Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global New Psychoactive Substance Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for New Psychoactive Substance in 2022
        3.2.3 Global Concentration Ratios (CR8) for New Psychoactive Substance in 2022
    3.3 New Psychoactive Substance Company Evaluation Quadrant
    3.4 New Psychoactive Substance Market: Overall Company Footprint Analysis
        3.4.1 New Psychoactive Substance Market: Region Footprint
        3.4.2 New Psychoactive Substance Market: Company Product Type Footprint
        3.4.3 New Psychoactive Substance Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: New Psychoactive Substance Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: New Psychoactive Substance Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: New Psychoactive Substance Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: New Psychoactive Substance Consumption Value Comparison
        4.2.1 United States VS China: New Psychoactive Substance Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: New Psychoactive Substance Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based New Psychoactive Substance Companies and Market Share, 2018-2023
        4.3.1 United States Based New Psychoactive Substance Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies New Psychoactive Substance Revenue, (2018-2023)
    4.4 China Based Companies New Psychoactive Substance Revenue and Market Share, 2018-2023
        4.4.1 China Based New Psychoactive Substance Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies New Psychoactive Substance Revenue, (2018-2023)
    4.5 Rest of World Based New Psychoactive Substance Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based New Psychoactive Substance Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies New Psychoactive Substance Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World New Psychoactive Substance Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Stimulants
        5.2.2 Cannabinoids
        5.2.3 Hallucinogens
        5.2.4 Depressants
    5.3 Market Segment by Type
        5.3.1 World New Psychoactive Substance Market Size by Type (2018-2023)
        5.3.2 World New Psychoactive Substance Market Size by Type (2024-2029)
        5.3.3 World New Psychoactive Substance Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World New Psychoactive Substance Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Cancer
        6.2.2 Neuropathic Disorders
        6.2.3 Spasticity
        6.2.4 Others
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World New Psychoactive Substance Market Size by Application (2018-2023)
        6.3.2 World New Psychoactive Substance Market Size by Application (2024-2029)
        6.3.3 World New Psychoactive Substance Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Zynerba Pharmaceuticals
        7.1.1 Zynerba Pharmaceuticals Details
        7.1.2 Zynerba Pharmaceuticals Major Business
        7.1.3 Zynerba Pharmaceuticals New Psychoactive Substance Product and Services
        7.1.4 Zynerba Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Zynerba Pharmaceuticals Recent Developments/Updates
        7.1.6 Zynerba Pharmaceuticals Competitive Strengths & Weaknesses
    7.2 GW Pharmaceuticals
        7.2.1 GW Pharmaceuticals Details
        7.2.2 GW Pharmaceuticals Major Business
        7.2.3 GW Pharmaceuticals New Psychoactive Substance Product and Services
        7.2.4 GW Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 GW Pharmaceuticals Recent Developments/Updates
        7.2.6 GW Pharmaceuticals Competitive Strengths & Weaknesses
    7.3 Teewinot Life Sciences
        7.3.1 Teewinot Life Sciences Details
        7.3.2 Teewinot Life Sciences Major Business
        7.3.3 Teewinot Life Sciences New Psychoactive Substance Product and Services
        7.3.4 Teewinot Life Sciences New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Teewinot Life Sciences Recent Developments/Updates
        7.3.6 Teewinot Life Sciences Competitive Strengths & Weaknesses
    7.4 AusCann
        7.4.1 AusCann Details
        7.4.2 AusCann Major Business
        7.4.3 AusCann New Psychoactive Substance Product and Services
        7.4.4 AusCann New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 AusCann Recent Developments/Updates
        7.4.6 AusCann Competitive Strengths & Weaknesses
    7.5 Cannabics Pharmaceuticals
        7.5.1 Cannabics Pharmaceuticals Details
        7.5.2 Cannabics Pharmaceuticals Major Business
        7.5.3 Cannabics Pharmaceuticals New Psychoactive Substance Product and Services
        7.5.4 Cannabics Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Cannabics Pharmaceuticals Recent Developments/Updates
        7.5.6 Cannabics Pharmaceuticals Competitive Strengths & Weaknesses
    7.6 Tilray
        7.6.1 Tilray Details
        7.6.2 Tilray Major Business
        7.6.3 Tilray New Psychoactive Substance Product and Services
        7.6.4 Tilray New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Tilray Recent Developments/Updates
        7.6.6 Tilray Competitive Strengths & Weaknesses
    7.7 Cyrelian
        7.7.1 Cyrelian Details
        7.7.2 Cyrelian Major Business
        7.7.3 Cyrelian New Psychoactive Substance Product and Services
        7.7.4 Cyrelian New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Cyrelian Recent Developments/Updates
        7.7.6 Cyrelian Competitive Strengths & Weaknesses
    7.8 Anandia Laboratories
        7.8.1 Anandia Laboratories Details
        7.8.2 Anandia Laboratories Major Business
        7.8.3 Anandia Laboratories New Psychoactive Substance Product and Services
        7.8.4 Anandia Laboratories New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Anandia Laboratories Recent Developments/Updates
        7.8.6 Anandia Laboratories Competitive Strengths & Weaknesses
    7.9 InMed Pharmaceuticals
        7.9.1 InMed Pharmaceuticals Details
        7.9.2 InMed Pharmaceuticals Major Business
        7.9.3 InMed Pharmaceuticals New Psychoactive Substance Product and Services
        7.9.4 InMed Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 InMed Pharmaceuticals Recent Developments/Updates
        7.9.6 InMed Pharmaceuticals Competitive Strengths & Weaknesses
    7.10 Renew Biopharma
        7.10.1 Renew Biopharma Details
        7.10.2 Renew Biopharma Major Business
        7.10.3 Renew Biopharma New Psychoactive Substance Product and Services
        7.10.4 Renew Biopharma New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Renew Biopharma Recent Developments/Updates
        7.10.6 Renew Biopharma Competitive Strengths & Weaknesses
    7.11 Cronos Group
        7.11.1 Cronos Group Details
        7.11.2 Cronos Group Major Business
        7.11.3 Cronos Group New Psychoactive Substance Product and Services
        7.11.4 Cronos Group New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Cronos Group Recent Developments/Updates
        7.11.6 Cronos Group Competitive Strengths & Weaknesses
    7.12 ICC International Cannabis
        7.12.1 ICC International Cannabis Details
        7.12.2 ICC International Cannabis Major Business
        7.12.3 ICC International Cannabis New Psychoactive Substance Product and Services
        7.12.4 ICC International Cannabis New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 ICC International Cannabis Recent Developments/Updates
        7.12.6 ICC International Cannabis Competitive Strengths & Weaknesses
    7.13 Biotii Technologies
        7.13.1 Biotii Technologies Details
        7.13.2 Biotii Technologies Major Business
        7.13.3 Biotii Technologies New Psychoactive Substance Product and Services
        7.13.4 Biotii Technologies New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Biotii Technologies Recent Developments/Updates
        7.13.6 Biotii Technologies Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 New Psychoactive Substance Industry Chain
    8.2 New Psychoactive Substance Upstream Analysis
    8.3 New Psychoactive Substance Midstream Analysis
    8.4 New Psychoactive Substance Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World New Psychoactive Substance Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World New Psychoactive Substance Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World New Psychoactive Substance Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World New Psychoactive Substance Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World New Psychoactive Substance Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World New Psychoactive Substance Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World New Psychoactive Substance Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World New Psychoactive Substance Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World New Psychoactive Substance Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key New Psychoactive Substance Players in 2022
    Table 12. World New Psychoactive Substance Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global New Psychoactive Substance Company Evaluation Quadrant
    Table 14. Head Office of Key New Psychoactive Substance Player
    Table 15. New Psychoactive Substance Market: Company Product Type Footprint
    Table 16. New Psychoactive Substance Market: Company Product Application Footprint
    Table 17. New Psychoactive Substance Mergers & Acquisitions Activity
    Table 18. United States VS China New Psychoactive Substance Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China New Psychoactive Substance Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based New Psychoactive Substance Companies, Headquarters (States, Country)
    Table 21. United States Based Companies New Psychoactive Substance Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies New Psychoactive Substance Revenue Market Share (2018-2023)
    Table 23. China Based New Psychoactive Substance Companies, Headquarters (Province, Country)
    Table 24. China Based Companies New Psychoactive Substance Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies New Psychoactive Substance Revenue Market Share (2018-2023)
    Table 26. Rest of World Based New Psychoactive Substance Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies New Psychoactive Substance Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies New Psychoactive Substance Revenue Market Share (2018-2023)
    Table 29. World New Psychoactive Substance Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World New Psychoactive Substance Market Size by Type (2018-2023) & (USD Million)
    Table 31. World New Psychoactive Substance Market Size by Type (2024-2029) & (USD Million)
    Table 32. World New Psychoactive Substance Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World New Psychoactive Substance Market Size by Application (2018-2023) & (USD Million)
    Table 34. World New Psychoactive Substance Market Size by Application (2024-2029) & (USD Million)
    Table 35. Zynerba Pharmaceuticals Basic Information, Area Served and Competitors
    Table 36. Zynerba Pharmaceuticals Major Business
    Table 37. Zynerba Pharmaceuticals New Psychoactive Substance Product and Services
    Table 38. Zynerba Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Zynerba Pharmaceuticals Recent Developments/Updates
    Table 40. Zynerba Pharmaceuticals Competitive Strengths & Weaknesses
    Table 41. GW Pharmaceuticals Basic Information, Area Served and Competitors
    Table 42. GW Pharmaceuticals Major Business
    Table 43. GW Pharmaceuticals New Psychoactive Substance Product and Services
    Table 44. GW Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. GW Pharmaceuticals Recent Developments/Updates
    Table 46. GW Pharmaceuticals Competitive Strengths & Weaknesses
    Table 47. Teewinot Life Sciences Basic Information, Area Served and Competitors
    Table 48. Teewinot Life Sciences Major Business
    Table 49. Teewinot Life Sciences New Psychoactive Substance Product and Services
    Table 50. Teewinot Life Sciences New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Teewinot Life Sciences Recent Developments/Updates
    Table 52. Teewinot Life Sciences Competitive Strengths & Weaknesses
    Table 53. AusCann Basic Information, Area Served and Competitors
    Table 54. AusCann Major Business
    Table 55. AusCann New Psychoactive Substance Product and Services
    Table 56. AusCann New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. AusCann Recent Developments/Updates
    Table 58. AusCann Competitive Strengths & Weaknesses
    Table 59. Cannabics Pharmaceuticals Basic Information, Area Served and Competitors
    Table 60. Cannabics Pharmaceuticals Major Business
    Table 61. Cannabics Pharmaceuticals New Psychoactive Substance Product and Services
    Table 62. Cannabics Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Cannabics Pharmaceuticals Recent Developments/Updates
    Table 64. Cannabics Pharmaceuticals Competitive Strengths & Weaknesses
    Table 65. Tilray Basic Information, Area Served and Competitors
    Table 66. Tilray Major Business
    Table 67. Tilray New Psychoactive Substance Product and Services
    Table 68. Tilray New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Tilray Recent Developments/Updates
    Table 70. Tilray Competitive Strengths & Weaknesses
    Table 71. Cyrelian Basic Information, Area Served and Competitors
    Table 72. Cyrelian Major Business
    Table 73. Cyrelian New Psychoactive Substance Product and Services
    Table 74. Cyrelian New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Cyrelian Recent Developments/Updates
    Table 76. Cyrelian Competitive Strengths & Weaknesses
    Table 77. Anandia Laboratories Basic Information, Area Served and Competitors
    Table 78. Anandia Laboratories Major Business
    Table 79. Anandia Laboratories New Psychoactive Substance Product and Services
    Table 80. Anandia Laboratories New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Anandia Laboratories Recent Developments/Updates
    Table 82. Anandia Laboratories Competitive Strengths & Weaknesses
    Table 83. InMed Pharmaceuticals Basic Information, Area Served and Competitors
    Table 84. InMed Pharmaceuticals Major Business
    Table 85. InMed Pharmaceuticals New Psychoactive Substance Product and Services
    Table 86. InMed Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. InMed Pharmaceuticals Recent Developments/Updates
    Table 88. InMed Pharmaceuticals Competitive Strengths & Weaknesses
    Table 89. Renew Biopharma Basic Information, Area Served and Competitors
    Table 90. Renew Biopharma Major Business
    Table 91. Renew Biopharma New Psychoactive Substance Product and Services
    Table 92. Renew Biopharma New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Renew Biopharma Recent Developments/Updates
    Table 94. Renew Biopharma Competitive Strengths & Weaknesses
    Table 95. Cronos Group Basic Information, Area Served and Competitors
    Table 96. Cronos Group Major Business
    Table 97. Cronos Group New Psychoactive Substance Product and Services
    Table 98. Cronos Group New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Cronos Group Recent Developments/Updates
    Table 100. Cronos Group Competitive Strengths & Weaknesses
    Table 101. ICC International Cannabis Basic Information, Area Served and Competitors
    Table 102. ICC International Cannabis Major Business
    Table 103. ICC International Cannabis New Psychoactive Substance Product and Services
    Table 104. ICC International Cannabis New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. ICC International Cannabis Recent Developments/Updates
    Table 106. Biotii Technologies Basic Information, Area Served and Competitors
    Table 107. Biotii Technologies Major Business
    Table 108. Biotii Technologies New Psychoactive Substance Product and Services
    Table 109. Biotii Technologies New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 110. Global Key Players of New Psychoactive Substance Upstream (Raw Materials)
    Table 111. New Psychoactive Substance Typical Customers
List of Figure
    Figure 1. New Psychoactive Substance Picture
    Figure 2. World New Psychoactive Substance Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World New Psychoactive Substance Total Market Size (2018-2029) & (USD Million)
    Figure 4. World New Psychoactive Substance Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World New Psychoactive Substance Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company New Psychoactive Substance Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company New Psychoactive Substance Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company New Psychoactive Substance Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company New Psychoactive Substance Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company New Psychoactive Substance Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company New Psychoactive Substance Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company New Psychoactive Substance Revenue (2018-2029) & (USD Million)
    Figure 13. New Psychoactive Substance Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World New Psychoactive Substance Consumption Value (2018-2029) & (USD Million)
    Figure 16. World New Psychoactive Substance Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States New Psychoactive Substance Consumption Value (2018-2029) & (USD Million)
    Figure 18. China New Psychoactive Substance Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe New Psychoactive Substance Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan New Psychoactive Substance Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea New Psychoactive Substance Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN New Psychoactive Substance Consumption Value (2018-2029) & (USD Million)
    Figure 23. India New Psychoactive Substance Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of New Psychoactive Substance by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for New Psychoactive Substance Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for New Psychoactive Substance Markets in 2022
    Figure 27. United States VS China: New Psychoactive Substance Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: New Psychoactive Substance Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World New Psychoactive Substance Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World New Psychoactive Substance Market Size Market Share by Type in 2022
    Figure 31. Stimulants
    Figure 32. Cannabinoids
    Figure 33. Hallucinogens
    Figure 34. Depressants
    Figure 35. World New Psychoactive Substance Market Size Market Share by Type (2018-2029)
    Figure 36. World New Psychoactive Substance Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World New Psychoactive Substance Market Size Market Share by Application in 2022
    Figure 38. Cancer
    Figure 39. Neuropathic Disorders
    Figure 40. Spasticity
    Figure 41. Others
    Figure 42. New Psychoactive Substance Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Zynerba Pharmaceuticals
GW Pharmaceuticals
Teewinot Life Sciences
AusCann
Cannabics Pharmaceuticals
Tilray
Cyrelian
Anandia Laboratories
InMed Pharmaceuticals
Renew Biopharma
Cronos Group
ICC International Cannabis
Biotii Technologies

Related Reports

Global New Psychoactive Substance Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global New Psychoactive Substance Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 08 Sep 2021

date Medical Care

The New Psychoactive Substance market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global New Psychoactive Substance Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global New Psychoactive Substance Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 18 Jan 2022

date Medical Care

Global New Psychoactive Substance Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global New Psychoactive Substance Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 30 Aug 2023

date Medical Care

According to our (Global Info Research) latest study, the global New Psychoactive Substance market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global New Psychoactive Substance Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global New Psychoactive Substance Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global New Psychoactive Substance market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global New Psychoactive Substance Supply, Demand and Key Producers, 2024-2030

Global New Psychoactive Substance Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Medical Care

The global New Psychoactive Substance market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

new psychoactive substance

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>